The University of Chicago Header Logo

Connection

Christine Bestvina to Exons

Back to Details
This is a "connection" page, showing publications Christine Bestvina has written about Exons.
Christine Bestvina
Connection Strength
0.044
Exons
  1. Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice. Clin Cancer Res. 2022 03 15; 28(6):1117-1126.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.